These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24452739)

  • 1. Prostate cancer nomograms: a review of their use in cancer detection and treatment.
    Caras RJ; Sterbis JR
    Curr Urol Rep; 2014 Mar; 15(3):391. PubMed ID: 24452739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using prostate-specific antigen screening and nomograms to assess risk and predict outcomes in the management of prostate cancer.
    Hammerer PG; Kattan MW; Mottet N; Prayer-Galetti T
    BJU Int; 2006 Jul; 98(1):11-9. PubMed ID: 16566811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nomogram for prediction of prostate cancer on multi-core biopsy using age, serum prostate-specific antigen, prostate volume and digital rectal examination in Singapore.
    Lee A; Lim J; Gao X; Liu L; Chia SJ
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e348-e355. PubMed ID: 27641069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay.
    Hansen J; Auprich M; Ahyai SA; de la Taille A; van Poppel H; Marberger M; Stenzl A; Mulders PF; Huland H; Fisch M; Abbou CC; Schalken JA; Fradet Y; Marks LS; Ellis W; Partin AW; Pummer K; Graefen M; Haese A; Walz J; Briganti A; Shariat SF; Chun FK
    Eur Urol; 2013 Feb; 63(2):201-9. PubMed ID: 22854248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of nomograms for early detection in prostate cancer.
    Snow DC; Klein EA
    J Natl Compr Canc Netw; 2010 Feb; 8(2):271-6. PubMed ID: 20141682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer: treatment-specific nomograms, biochemical recurrence, and prostate cancer-specific mortality.
    Phillips R
    Nat Rev Urol; 2014 Dec; 11(12):657. PubMed ID: 25330792
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
    Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A
    Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer antigen-3 (PCA3) and PCA3-based nomograms in the diagnosis of prostate cancer: an external validation of Hansen's nomogram on a Norwegian cohort.
    Nygård Y; Haukaas SA; Eide GE; Halvorsen OJ; Gravdal K; Frugård J; Akslen LA; Beisland C
    Scand J Urol; 2015 Feb; 49(1):8-15. PubMed ID: 25141128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radical prostatectomy versus radiation therapy: can pretreatment nomograms be used to select the appropriate prostate cancer treatment?
    Simon RM; Salama JK; Freedland SJ
    Eur Urol; 2015 Feb; 67(2):210-1. PubMed ID: 25457494
    [No Abstract]   [Full Text] [Related]  

  • 10. Point: Impact of prostate-specific antigen velocity on management decisions and recommendations.
    Loeb S; Carter HB
    J Natl Compr Canc Netw; 2013 Mar; 11(3):281-5. PubMed ID: 23486454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence.
    Lee BH; Kibel AS; Ciezki JP; Klein EA; Reddy CA; Yu C; Kattan MW; Stephenson AJ
    Eur Urol; 2015 Feb; 67(2):204-9. PubMed ID: 25294696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A catalog of prostate cancer nomograms.
    Ross PL; Scardino PT; Kattan MW
    J Urol; 2001 May; 165(5):1562-8. PubMed ID: 11342918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer risk assessment tools in an unscreened population.
    Lundon DJ; Kelly BD; Foley R; Loeb S; Fitzpatrick JM; Watson RW; Rogers E; Durkan GC; Walsh K
    World J Urol; 2015 Jun; 33(6):827-32. PubMed ID: 25091862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk assessment models to evaluate the necessity of prostate biopsies in North Chinese patients with 4-50 ng/mL PSA.
    Zhao J; Liu S; Gao D; Ding S; Niu Z; Zhang H; Huang Z; Qiu J; Li Q; Li N; Xie F; Cui J; Lu J
    Oncotarget; 2017 Feb; 8(6):9935-9946. PubMed ID: 28039477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of nomograms for stratification of men at risk of prostate cancer prior to prostate biopsy.
    Schmid M; Hansen J; Rink M; Fisch M; Chun F
    Biomark Med; 2013 Dec; 7(6):843-50. PubMed ID: 24266817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of nomograms in the detection of prostate cancer.
    Roobol MJ
    Prostate; 2006 Sep; 66(12):1266-7. PubMed ID: 16752374
    [No Abstract]   [Full Text] [Related]  

  • 17. Development, validation and comparison of two nomograms predicting prostate cancer at initial 12-core biopsy.
    Nowroozi MR; Amini S; Kasaeian A; Zavarehei MJ; Eshraghian MR; Ayati M
    Asia Pac J Clin Oncol; 2016 Jun; 12(2):e289-97. PubMed ID: 24684767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session in the era of extended prostate sampling.
    Moussa AS; Jones JS; Yu C; Fareed K; Kattan MW
    BJU Int; 2010 Nov; 106(9):1309-14. PubMed ID: 20438566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer: A valuable tool for prediction of repeat biopsy pathology.
    Karakiewicz P; Nazzani S
    Nat Rev Urol; 2018 Mar; 15(3):140-141. PubMed ID: 29283172
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparison of two on-line risk calculators versus the detection of circulating prostate cells for the detection of high risk prostate cancer at first biopsy.].
    Murray NP; Fuentealba C; Reyes E; Jacob O
    Arch Esp Urol; 2017 Jun; 70(5):503-512. PubMed ID: 28613202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.